Aptevo Therapeutics APVO
NASDAQ APVO
$2.68 -0.08 (-2.81%)
As of: Aug 21, 2026 · 3:59 PM EDT

Aptevo Therapeutics (APVO) Property, Plant & Equipment (Net) (2015 - 2026)

Aptevo Therapeutics (APVO) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Aptevo Therapeutics 3.18 Mn -6.61 Mn - 236,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 236,000.00
Jun 30, 2026 236,000.00
Mar 31, 2026 268,000.00
Mar 31, 2026 268,000.00
Dec 31, 2025 303,000.00
Dec 31, 2025 303,000.00
Sep 30, 2025 384,000.00
Sep 30, 2025 384,000.00
Jun 30, 2025 432,000.00
Jun 30, 2025 432,000.00
Mar 31, 2025 482,000.00
Mar 31, 2025 482,000.00
Dec 31, 2024 543,000.00
Dec 31, 2024 543,000.00
Sep 30, 2024 614,000.00
Sep 30, 2024 614,000.00
Jun 30, 2024 697,000.00
Jun 30, 2024 697,000.00
Mar 31, 2024 789,000.00
Mar 31, 2024 789,000.00